ATE84708T1 - Antacidzusammensetzungen mit laengerer verweilzeit im magen. - Google Patents

Antacidzusammensetzungen mit laengerer verweilzeit im magen.

Info

Publication number
ATE84708T1
ATE84708T1 AT89304013T AT89304013T ATE84708T1 AT E84708 T1 ATE84708 T1 AT E84708T1 AT 89304013 T AT89304013 T AT 89304013T AT 89304013 T AT89304013 T AT 89304013T AT E84708 T1 ATE84708 T1 AT E84708T1
Authority
AT
Austria
Prior art keywords
stomach
antacid
longer time
antacid compositions
solid
Prior art date
Application number
AT89304013T
Other languages
English (en)
Inventor
Robert Geoffrey Willi Spickett
Jose Luis Fabregas Vidal
Juan Cucala Escoi
Original Assignee
Walton Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Walton Sa filed Critical Walton Sa
Application granted granted Critical
Publication of ATE84708T1 publication Critical patent/ATE84708T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT89304013T 1988-04-21 1989-04-21 Antacidzusammensetzungen mit laengerer verweilzeit im magen. ATE84708T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB888809421A GB8809421D0 (en) 1988-04-21 1988-04-21 Antacid compositions with prolonged gastric residence time
EP89304013A EP0338861B1 (de) 1988-04-21 1989-04-21 Antacidzusammensetzungen mit längerer Verweilzeit im Magen

Publications (1)

Publication Number Publication Date
ATE84708T1 true ATE84708T1 (de) 1993-02-15

Family

ID=10635574

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89304013T ATE84708T1 (de) 1988-04-21 1989-04-21 Antacidzusammensetzungen mit laengerer verweilzeit im magen.

Country Status (19)

Country Link
US (1) US5288506A (de)
EP (1) EP0338861B1 (de)
JP (1) JPH0764724B2 (de)
KR (1) KR950007205B1 (de)
AT (1) ATE84708T1 (de)
AU (1) AU616257B2 (de)
CA (1) CA1336495C (de)
DE (1) DE68904459T2 (de)
DK (1) DK188489A (de)
ES (1) ES2044099T3 (de)
FI (1) FI98886C (de)
GB (1) GB8809421D0 (de)
GR (1) GR3006908T3 (de)
HU (1) HU211236A9 (de)
IE (1) IE61866B1 (de)
NO (1) NO176868C (de)
NZ (1) NZ228836A (de)
PT (1) PT90328B (de)
ZA (1) ZA892920B (de)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ225893A3 (en) * 1991-04-04 1994-04-13 Procter & Gamble Chewing antacid preparation
FR2677546B1 (fr) * 1991-06-12 1994-01-21 Fabienne Joanny Composition therapeutique pour liberation prolonge de magnesium.
GB9310412D0 (en) * 1993-05-20 1993-07-07 Danbiosyst Uk Nasal nicotine system
US5622980A (en) * 1993-08-17 1997-04-22 Applied Analytical Industries, Inc. Oral compositions of H2-antagonists
DE4415999A1 (de) * 1994-05-06 1995-11-09 Bolder Arzneimittel Gmbh Magensäurebindende Kaupastillen
JP2683454B2 (ja) * 1994-06-06 1997-11-26 山之内製薬株式会社 固形制酸剤及びその製造法
US6306828B1 (en) * 1995-04-06 2001-10-23 Baxter International, Inc. Enantiomerically-enhanced nutritional energy substrates
WO1997019699A1 (en) * 1995-11-27 1997-06-05 Yamanouchi Pharmaceutical Co., Ltd. Drug composition
US6699885B2 (en) * 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6645988B2 (en) * 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US6489346B1 (en) * 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
SE9600071D0 (sv) * 1996-01-08 1996-01-08 Astra Ab New oral formulation of two active ingredients I
US6096340A (en) * 1997-11-14 2000-08-01 Andrx Pharmaceuticals, Inc. Omeprazole formulation
US6174548B1 (en) 1998-08-28 2001-01-16 Andrx Pharmaceuticals, Inc. Omeprazole formulation
US6733778B1 (en) * 1999-08-27 2004-05-11 Andrx Pharmaceuticals, Inc. Omeprazole formulation
FR2793688B1 (fr) * 1999-05-21 2003-06-13 Ethypharm Lab Prod Ethiques Microgranules gastroproteges, procede d'obtention et preparations pharmaceutiques
CN1252154C (zh) 1999-07-22 2006-04-19 沃纳-兰伯特公司 支链淀粉膜组合物
US6268385B1 (en) 1999-08-26 2001-07-31 Robert R. Whittle Dry blend pharmaceutical formulations
US6312712B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Method of improving bioavailability
US6780880B1 (en) 1999-08-26 2004-08-24 Robert R. Whittle FT-Raman spectroscopic measurement
US6262085B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6369087B1 (en) * 1999-08-26 2002-04-09 Robert R. Whittle Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6312723B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Pharmaceutical unit dosage form
US6316020B1 (en) 1999-08-26 2001-11-13 Robert R. Whittle Pharmaceutical formulations
US6262086B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Pharmaceutical unit dosage form
US6326384B1 (en) 1999-08-26 2001-12-04 Robert R. Whittle Dry blend pharmaceutical unit dosage form
EP1245227A1 (de) * 2001-03-31 2002-10-02 Jagotec Ag Pharmazeutische, im Magen aufschwimmende Tablette für die programmierte Freisetzung des Wirkstoffes und Verfahren zur Herstellung des in der Tablette enthaltenen schwimmfähigen Materials
SE0101379D0 (sv) 2001-04-18 2001-04-18 Diabact Ab Komposition som hämmar utsöndring av magsyra
WO2003063840A2 (en) * 2002-01-25 2003-08-07 Santarus, Inc. Transmucosal delivery of proton pump inhibitors
SE0203065D0 (sv) 2002-10-16 2002-10-16 Diabact Ab Gastric acid secretion inhibiting composition
TWI367759B (en) * 2003-02-20 2012-07-11 Santarus Inc A novel formulation, omeprazole antacid complex-immediate release, for rapid and sustained suppression of gastric acid
US20050220870A1 (en) * 2003-02-20 2005-10-06 Bonnie Hepburn Novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid
CA2531564C (en) * 2003-07-18 2016-01-19 Santarus, Inc. Pharmaceutical composition for inhibiting acid secretion
US8993599B2 (en) * 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
AU2004257864A1 (en) * 2003-07-18 2005-01-27 Santarus, Inc. Pharmaceutical formulation and method for treating acid-caused gastrointestinal disorders
US20070292498A1 (en) * 2003-11-05 2007-12-20 Warren Hall Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers
US8815916B2 (en) * 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) * 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
JP2006131581A (ja) * 2004-11-09 2006-05-25 Kyowa Chem Ind Co Ltd 崩壊剤及びこれを含有する崩壊性成形物
US20100297226A1 (en) * 2006-06-01 2010-11-25 Dexcel Pharma Technologies Ltd. Multiple unit pharmaceutical formulation
US20090092658A1 (en) * 2007-10-05 2009-04-09 Santarus, Inc. Novel formulations of proton pump inhibitors and methods of using these formulations
HUE025008T2 (en) 2012-10-12 2016-04-28 Omya Int Ag Gastro-reactive pharmaceutical composition and delivery systems and method for their preparation using functionalized calcium carbonate
EP3034070A1 (de) 2014-12-18 2016-06-22 Omya International AG Verfahren zur Herstellung eines pharmazeutischen Abgabesystems
EP3069713A1 (de) 2015-03-20 2016-09-21 Omya International AG Dispergierbare dosierungsform
US20170042806A1 (en) 2015-04-29 2017-02-16 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
CA2898600A1 (en) 2015-07-28 2017-01-28 Jayson King Stuffing box containment apparatus
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
EP3269361A1 (de) 2016-07-14 2018-01-17 Omya International AG Darreichungsform
CN110327370B (zh) * 2019-04-16 2021-02-23 马德君 阴离子黏土用于制备驱铅药物的用途
CN110780063A (zh) * 2019-12-10 2020-02-11 无锡市尚沃医疗电子股份有限公司 一种呼气氨检测方法和装置

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1416304A (fr) * 1961-10-10 1965-11-05 Smith Kline French Lab Perfectionnements apportés aux tablettes et comprimés renfermant une importante quantité d'ingrédient actif libéré pendant un laps de temps prolongé, et aux procédés pour leur préparation
CA948107A (en) * 1970-04-28 1974-05-28 Robert S. Joslin Coated antacid compositions of improved taste
US4101650A (en) * 1977-04-06 1978-07-18 Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai Pepstatin floating minicapsules
HU179474B (en) * 1978-02-24 1982-10-28 Laszlo Gyarmati Process for preparing solid oral pharmaceutical compositons with increased length of activity and with a regulated release of the active material
MTP930B (en) * 1982-04-30 1984-04-10 Delandale Labs Ltd Substained release lithium-containing tablets and method for their manufacture
US4605551A (en) * 1984-11-30 1986-08-12 William H. Rorer, Inc. Dry oil coated antacid process
US4778676A (en) * 1985-12-20 1988-10-18 Warner-Lambert Company Confectionery delivery system for actives
JPS62195323A (ja) * 1986-02-24 1987-08-28 Eisai Co Ltd 胃内滞留型粒子
WO1988000051A1 (en) * 1986-06-24 1988-01-14 Racz Istvan Proceeding for the production of pharmaceutical preparations of high gastric acid binding capacity, of retarded effect and of increased bioavailability

Also Published As

Publication number Publication date
FI98886B (fi) 1997-05-30
HU211236A9 (en) 1995-11-28
NO176868C (no) 1995-06-14
US5288506A (en) 1994-02-22
KR890015733A (ko) 1989-11-25
NZ228836A (en) 1990-09-26
DE68904459D1 (de) 1993-03-04
FI891896A0 (fi) 1989-04-20
NO891641D0 (no) 1989-04-20
JPH0764724B2 (ja) 1995-07-12
KR950007205B1 (ko) 1995-07-04
PT90328A (pt) 1989-11-10
ZA892920B (en) 1989-12-27
PT90328B (pt) 1994-11-30
JPH0215025A (ja) 1990-01-18
FI98886C (fi) 1997-09-10
EP0338861A2 (de) 1989-10-25
GB8809421D0 (en) 1988-05-25
NO891641L (no) 1989-10-23
EP0338861A3 (en) 1990-09-19
CA1336495C (en) 1995-08-01
DK188489A (da) 1989-10-23
GR3006908T3 (de) 1993-06-30
DK188489D0 (da) 1989-04-19
DE68904459T2 (de) 1993-05-13
NO176868B (no) 1995-03-06
IE61866B1 (en) 1994-11-30
IE891282L (en) 1989-10-21
FI891896L (fi) 1989-10-22
AU616257B2 (en) 1991-10-24
ES2044099T3 (es) 1994-01-01
AU3317589A (en) 1989-10-26
EP0338861B1 (de) 1993-01-20

Similar Documents

Publication Publication Date Title
DE68904459D1 (de) Antacidzusammensetzungen mit laengerer verweilzeit im magen.
ITMI912212A1 (it) Composizioni farmaceutiche solide per somministrazione orale aventi proungata residenza gastrica
HUT58509A (en) Drug administering instrument ensuring controlled release of active ingredient
DE3875425D1 (de) Vasokinetisch wirkende polyungesaettigte saeuren und sie enthaltende pharmazeutische oder kosmetische zubereitungen.
GB8730011D0 (en) Pharmaceutical compositions
DE68915695D1 (de) Zubereitungen mit kontrollierter Wirkstoffabgabe.
DE68904119D1 (de) Dosisformen mit definiertem wassergehalt zur gesteuerten freigabe.
ES2077766T3 (es) Preparacion antiacidos con tiempo prolongado de residencia en el estomago.
AU7264187A (en) Formulations containing unsaturated fatty acids for the synthesis of prostaglandins and hydroxy-fatty acids in biological systems
AU2472888A (en) Method of solidification and encapsulation using core-shell polymer particles
ES2018952A6 (es) Procedimiento de preparacion de composiciones antiacidas con tiempo prolongado de permanencia gastrica.
ATE143805T1 (de) Arzneizubereitung mit hohem gehalt an ibuprofenlysinat
AU6886987A (en) Veterinary compositions incorporating a water swellable polymer
DE3879545D1 (de) Polymer-teilchen.
ATE19855T1 (de) Pharmazeutische und diaetetische zusammensetzung.
ES2045366T3 (es) Procedimiento para la preparacion de l-fosfinotricina.
GB2213062A (en) Pharmaceutical preparation having oestrogen action

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
REN Ceased due to non-payment of the annual fee